Shane Ward
CIK 1638380 · COO & CLO · last filed 2026-01-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
29
Lifetime Open-Market Net
-$2.31M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cidara Therapeutics, Inc. (CDTX) Delisted | COO & CLO | 0 | $221.38 | $0 | -$2.25M | 11 | 2026-01-07 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Sr VP and Chief Legal SO | 1,879 | $0.07 | $141 | $9.8K | 8 | 2020-06-02 |
| Aravive, Inc. (VSAR) Delisted | SVP and General Counsel | 201,556 | — | — | -$68.6K | 10 | 2018-02-12 |
Recent Filings · Page 2 of 3
29 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-27 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-02 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Tax (F) | −107 | -$816 | EDGAR |
| 2020-04-09 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-04 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-08-30 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Buy (P) | +8,000 | $9.8K | EDGAR |
| 2019-06-11 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-30 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Tax (F) | −1,065 | -$2.2K | EDGAR |
| 2019-02-05 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-29 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2018-02-12 | Aravive, Inc. (VSAR) Delisted | Sell (S) | −4,118 | -$7.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.